Tuesday, October 27, 2020

Protein Mapping Study Reveals Valuable Clues for COVID-19 Drug Development

Blog

Based on the NIH health information topics you requested to receive information about, we thought you'd be interested in this story from the NIH Director's Blog.

Drug Development

Protein Mapping Study Reveals Valuable Clues for COVID-19 Drug Development

Posted on  by Dr. Francis Collins

One way to fight COVID-19 is with drugs that directly target SARS-CoV-2, the novel coronavirus that causes the disease. That's the strategy employed by remdesivir, the only antiviral drug currently authorized by the U.S. Food and Drug Administration to treat COVID-19. Another promising strategy is drugs that target the proteins...

Read More ...


This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612 GovDelivery logo

No comments:

Post a Comment